申请人:Bayer Aktiengesellschaft
公开号:US05318988A1
公开(公告)日:1994-06-07
Aminomethyl-chromans are obtained by alkylation of correspondingly substituted amines or by reductive amination of correspondingly substituted aldehydes. The aminomethyl-chromans can be used as active compounds in medicaments, in particular for the treatment of diseases of the central nervous system.
Aminomethyl-chromans是通过烷基化相应取代胺或还原胺化相应取代醛得到的。这些化合物可以作为药物的活性成分,特别是用于治疗中枢神经系统疾病。